Related Experiment Video
Updated: Oct 3, 2025
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.6K
Phenotyping of CAR T cells
1Department of Immunology, University of Pittsburgh, Pittsburgh, PA, United States.
Methods in Cell Biology
|February 14, 2022
Summary
Chimeric antigen receptor (CAR) T cell therapy shows promise for treating cancers. Immunophenotypic characterization of CAR-T cells using flow cytometry is crucial for ensuring treatment efficacy and quality control.
Area of Science:
- Immunology
- Cell Therapy
- Biotechnology
Background:
- Adaptive immunotherapy, including chimeric antigen receptor (CAR) T cells, is an emerging therapeutic strategy for various diseases.
- CAR T cells are engineered T cells designed to target specific antigens on cancer cells, offering potential treatments for hematologic malignancies and solid tumors.
Purpose of the Study:
- To highlight the importance of immunophenotypic characterization of CAR T cells during the bioprocess.
- To propose a flow cytometry-based method for analyzing CAR T cell phenotype and subsets.
Main Methods:
- Flow cytometry-based immunophenotyping analysis.
- Characterization of CAR T cell subsets.
Main Results:
- The study proposes a method for defining the phenotype of CAR T cell subsets.
- This characterization is critical for quality control in CAR T cell bioprocessing.
Conclusions:
- Immunophenotypic profiling of CAR T cells is essential for optimizing cell quality.
- Effective quality control of CAR T cells can enhance their antitumor efficacy in clinical applications.
Keywords:
Adaptive immunotherapyCAR-T cellsCentral memory T cellEffector T cellEffector memory T cellFlow cytometryImmunophenotypic analysisMemory stem T cellsNaive T cellT cells subsets
